Pancreatic Neuroendocrine Carcinoma
📧 Sign up to get email alerts when something new happens for Pancreatic Neuroendocrine Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-08Clinical Trial Update: Cisplatin and Etoposide Versus Temozolomide and Capecitabine in Patients With Advanced Poorly Differentiated (G3) Non-Small Cell Gastrointestinal Neuroendocrine Carcinomas [Phase 2]
A Phase 2 trial comparing cisplatin/etoposide to temozolomide/capecitabine in patients with advanced poorly differentiated gastrointestinal …
-
CLINICAL_TRIALS trial_result · 2023-12-19Clinical Trial Update: Liposomal Irinotecan, Fluorouracil and Leucovorin in Treating Patients With Refractory Advanced High Grade Neuroendocrine Cancer of Gastrointestinal, Unknown, or Pancreatic Origin [Phase 2]
Phase 2 trial evaluating liposomal irinotecan with fluorouracil and leucovorin in patients with refractory advanced high-grade neuroendocrin…
-
CLINICAL_TRIALS trial_result · 2015-04-01Clinical Trial Update: Pazopanib Hydrochloride in Treating Patients With Advanced Neuroendocrine Cancer [Phase 2]
Phase 2 trial investigating pazopanib hydrochloride in advanced neuroendocrine tumors; results completed and posted in 2015.